Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages by unknown
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The activation of differentiated macrophages during an inflammatory reaction
is accompanied by an increase in the transcription ofmany genes whose products
arenecessary forthese cells' effector functions, and by an accumulation ofthe corre-
sponding mRNAs(1-3) . Tumornecrosis factor(TNFa, cachectin) is a majorcytokine
produced by macrophages . Among its pleitropic effects, TNFa is apotent inducer
ofa variety of inflammatory reactions, and plays a major role in the development
of endotoxic shock (4-6). AlthoughTNFcan also be produced by lymphocytes (7-10),
macrophages seem to be its most abundant source .
The mouseTNF locus, which is located at the boundary ofthe class III and class
I regions of theMHC, comprises two very closely linked genes, coding for TNFa
andTNF(3 (lymphotoxin) (11-13) . We have previously shown that the TNF0 pro-
moter is silent in macrophages, while theTNFa promoter is inducible by LPS and
IFN-y (2, 3, 10) . In the present study, we attempted to map theDNA sequence ele-
ments that are required for LPS inducibility of the TNFa promoter in cultured
primary macrophages, andto identify LPS-induced factors that may bind to them .
We found evidence suggesting major roles in LPS-mediated transcriptional activa-
tion for one or more enhancers of the "KB" family, and for aY box similar to that
found in the promoter of MHC class II genes .
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Materials and Methods
Construction ofDNA Clones .
￿
Theplasmids containing the bacterial chloramphenicol acetyl
transferase (CAT)' gene linked to the SV40 early promoter (pSV2CAT), the promoterless
pSVOCAT, and the pBLCAT3 and pBLCAT2 vectors, have been previously described (14,
t5) . ThepSV2GH plasmid, with thehuman growth hormone(HGH)gene underthe control
Address correspondence to Dr. C. Victor Jongeneel, Ludwig Institute for Cancer Research, Ch . des
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' Abbreviations used in this paper: CAT, chloramphenicol acetyl transferase ; HGH, human growth
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ofthe SV40 early promoter, was generated by inserting a 557-bp Hind III to Nde I fragment
from pSV2CAT into pOGH (16) cut with Hind III and Nde I .
All oftheTNFpromoter constructs used in this study were derived from a XEMBL3 genomic
clone containing most of the mouse (strain C57B1/6) TNF locus (11, 17) (Fig . 1) . Barn HI
to Nar I or Sac I to Nar I genomic fragments were cloned into thepBLCAT3 vector to generate
TNF(-1059)CAT and TNF(-695)CAT, respectively. An Eco RI to Nar I genomic fragment
(nt -655 to +138 relative to the TNFa cap site) was cloned in pGEM3 (Promega Biotec,
Madison, WI), and deletions were generated by successive digestions with Eco RI, exonu-
clease III(New England Biolabs, Beverly, MA), Mung bean nuclease (Pharmacia, Uppsala,
Sweden), and Hind III, and recloning of size-selected DNA fragments intopGEM3 cut with
Sma I and Hind III . The deleted promoter fragments were then introduced (as Hind III
to EcoR I fragments) into the Hind III site of pSVOCAT The endpoints of the deletions
were established by sequencing theTNF promoter/CAT hybrids (Fig . 5) . Further sequencing
detected the presence of a short (170 nt) piece of extraneous vector DNA 3' of the TNF se-
quence in the deletion mutants, which was found not to influence promoter activity (data
not shown) .
TheKB/TK constructs were made by insertingadouble-stranded oligonucleotide containing
a mouse TNFa KB enhancer (Fig. 5 ; site 3 in Figs . 1 and 7) and Hind III cohesive ends
into the Hind III site of the pBLCAT2 vector. The sequence of the oligonuclectide was as
follows :
TAGCTCAAACAGGGGGCTTTCCCTCCTC 3'
3' GTTTGTCCCCCGAAAGGGAGGAGTCGA5'
The copy number and orientation of the inserted oligonucleotides were established by se-
quencing.
S1 Nuclease Mapping .
￿
Single strand-specific nuclease protection mapping was done by stan-
dard protocols, using 500 U of Sl or Mung bean nucleases (Pharmacia) and 5 hg of total
cytoplasmic RNA per hybridization .
Transfection ofBone Marrow-derived Macrophages .
￿
Macrophages were generated from bone
marrow cells of C57B1/6 mice (Iffa Credo, L'Arbresle, France) by cultivating them for 10 d
in Dulbecco's minimal essential medium(DMEM) supplemented with 20% horse serum and
30% L cell-conditioned medium (a source of macrophage [M]-CSF) . These cell prepara-
tions contain >99% macrophages, asjudged by standard histochemical techniques (18) . For
transfections, cells were washed twice in serum-freeDMEM and resuspended at 10 7 cells/ml
inDMEM containing 25014g/ml DEAE-dextran (mol wt -500,000, Pharmacia) and 50mM
FIGURE 1 .
￿
Structure ofthe mouseTNF locus. Numberingofthe sequence is according to Semon
et al. (17) . The coding parts of the exons are shaded . The region of the locus used for studies
of the TNFa promoter and its salient features are marked above the map.SHAKHOV ET AL .
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Tris/HCI (pH 7 .5) . After addition of DNA (5 Wg/10' cells), the cells were incubated for 90
min at 37 °C with occasional shaking to avoid clumping. DMSO was added to a final concen-
tration of 10%, the cells were kept for 2-3 min at room temperature, and diluted 10-fold
withDMEM . After two washes in DMEM, the cells were returned to culture in complete
medium . LPS (form Wfrom Escherichia coli 055:115 ; Difco Laboratories, Detroit, Michigan)
was added between 24 and 36 h after transfection . CAT assays were performed on crude
cell extracts 48 h after transfection, using '4C-labeled chloramphenicol (Amersham plc,
Amersham, UK) as a substrate, and thin-layer chromatography to separate the native and
acetylated forms (14) . The culture medium was assayed for human growth hormone using
a sandwich RIA (Nichols Institute, San Juan Capistrano, CA) .
Preparation ofNuclear Extractsfrom Peritoneal Macrophages .
￿
Peritoneal exudate cells were pre-
pared from 3-mo-oldCBA/CA mice 4 d after a single 1.5-ml i.p . injection ofaged thioglycol-
late broth (Difco Laboratories) . To obtain activated macrophages, 0.5 ml ofLPS (20 p,g/ml
in PBS) was injected intraperitoneally 45min before harvesting the total exudate population.
Nuclei were obtained by breaking cells swollen in hypotonic buffer (10mM Hepes, pH 7.9,
0.75 mM spermidine, 0.15 mM spermine, 0 .1 mM EDTA, 0 .1 mM EGTA, 10 mM KCI,
1 mM DTT, 5 mg/ml powdered nonfat milk, 0.5mM PMSF, 1% (wt/vol) aprotinin, and
50 t~g/ml each pepstatin A, leupeptin, chymostatin, and antipain) with three strokes of a B
pestle in a Dounce homogenizer . The same cocktail of protease inhibitors was added to all
subsequent buffers . Preparation ofnuclear extracts essentially followed the procedure ofGorski
et al . (19) .
Gel Retardation Assays.
￿
For binding reactions, 0.1-1 ng of radiolabeled fragment (10,000-
20,000 cpm) was mixed with 12 Wg (protein) of nuclear extract in a total volume of 20 p.l
of 25 mM Hepes, pH 7.9, 0.5 mM EDTA, 0.5 mM DTT, 12% (vol/vol) glycerol, 40 mM
KCI . 2 wg of poly(dI :dC) and 0.5 l~g of denatured E. coli DNA were added to all reactions
as nonspecific competitors . After 30 min of incubation at room temperature, the reaction
mixtures were loaded on 4% polyacrylamide gels in low ionic strength buffer (0.25 x TBE) .
The gels were pre-run for at least 1 h at 20 V/cm and run for 3 h at the same voltage . After
electrophoresis, the gels were dried and exposed for autoradiography for a few hours .
Results
Mapping ofthe 5' End ofTNF-o : mRNA .
￿
To have a reference point for the location
of the TNFci promoter elements, we precisely mapped themRNA 5' end in single
strand-specific nuclease protection assays. We Tend-labeled aXma III (nt 4339)
to Nar I (nt 4498) fragment at the Nar I site and hybridized it to total cytoplasmic
RNA extracted from resting or LPS-stimulated peritoneal macrophages . The sizes
ofthe fragments protected fromMungbean or Sl nuclease digestion were compared
with an A+G ladder of the probe (Fig . 2 ; the heavy band near the top of the gel
corresponds to undegraded probe) . The result shows some heterogeneity in the 5'
end of the mRNA, with one major and three minor initiation sites . Three of the
four sites contain the canonical CA dinucleotide found at the cap sites ofmost eu-
karyotic mRNAs. We used themajor start site (nt 4360) as position + 1 in a zero-less
numbering scheme.
Transient Expression of TransfectedDNA in Bone Marrow-derivedMacrophages.
￿
Primary
macrophages accumulate large amounts ofTNFac mRNA after exposure to LPS,
and this accumulation is due at least in part to increased transcription of theTNFa
gene (2, 3, 10, 20) . Bone marrow-derived macrophages could be successfully trans-
fected (as judged by CAT expression from the pSV2CAT plasmid) up to 12 d after
initial culturing. Transfection with the pSV2GH plasmid resulted in the secretion
of significant amounts (up to 60 ng/ml) ofHGH into the culture medium . In subse-
quent experiments, we co-transfected test plasmids containing the CAT reporter gene38
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FIGURE 2 .
￿
Mapping oftheTNFa mRNA
5' end . An Xma III to Nar I restriction frag-
ment from theTNFa gene, labeled at theNar
I site, was hybridized to total cytoplasmic
RNA from resting or LPS-stimulated perito-
neal macrophages, and the fragments pro-
tected from Sl orMung bean (mb) nuclease
digestion were analyzed in adenaturing gel .
TheA+Glane shows the pattern obtained by
chemically cleaving the probe at purines. The
arrows pointing to the four protected frag-
ments correspond to those indicated on the
nudeotide sequence at the bottom of the figure.
with pSV2GH, and controlled transfection efficiencies by measuring theHGH con-
centration in the culture medium . Co-transfection with pSV2GH affected neither
the level ofexpression northe inducibility ofthe TNF/CAT constructs (data not shown).
LPS-induciblePromoterActivity ofSDeletions ofthe TNF-a Upstream Region.
￿
We con-
structed a series of nested deletions of the TNFa 5' flanking region, starting at nt
-1059, and with a common 3' end at nt +138, before the TNFci initiation codon .
These promoter fragments, coupled to the CAT coding region (see Materials and
Methods), were co-transfected with the pSV2GH plasmid into bone marrow-de-
rived macrophages, and cell extracts were assayed forCAT activity 2 d later. The
results of one such experiment are shown in Fig . 3 . Plasmids TNF(-1059)CAT,
TNF(-695)CAT and TNF(-655)CAT had a strongly LPS-inducible promoter ac-
tivity, which was greatly reduced in TNF(-451)CAT, and in all subsequent dele-
tions.A second drop in inducibility by LPSoccurred between nt -301 and nt -241
(Fig . 3) . Constructs containing less than 241 nt of the TNFcx promoter were no
longer able to respond to LPS . Although the level of inducibility by LPS varied be-
tween experiments, the reductions in LPS-inducedexpression between nt -655 and
-451 and between nt -301 and -241 were observed in four independent experi-
ments. Within therange (nt -1059 to -109) thatwe coveredwith our set ofdeletion
mutants, therewasno evidence indicating thepresence ofnegative regulatory elements.
Sequence-specific DNA-binding Activities Induced by LPS
￿
Using the gel retardation
assay, we tested whether proteins capable ofbinding to theTNFa upstream sequences
defined above were induced by LPS in nuclear extracts of peritoneal macrophages .
End-labeled restriction fragments spanning nt -695 to -432 (Sac I to Nco I) andSHAKHOV ET AL.
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FIGURE 3 .
￿
Inducibility ofTNFa promoter/CAT constructs byLPS . Macrophages were trans-
fected withTNF/CAT constructs andpSV2GH as described in MaterialsandMethods, and split
into control and LPS-induced (100 ng/ml) samples 24 h after transfection . CAT assays were per-
formed on crude cell extracts 16 h later, and transfection efficiencies were monitored by mea-
suringthe concentration ofHGH in the culture medium . TheKB/TK plasmids were constructed
by inserting a rcB-containing oligonucleotide upstream of the HSVTK gene of the pBLCAT2
vector, as described in Materialsand Methods . Their structure is as follows, with (+ or -) indi-
cating the orientation of the oligonucleotide relative to that found in the TNFa gene: rvB/TK
1:(-X+X-) ; rcB/TK 3:(-); rcB/TK 5:(+X+X+X+X+X+) ; r(B/TK 10:(+X+) .The relativeamounts
of acetylated chloramphenicol generated by LPS-stimulated transfectants, determined by den-
sitometry and corrected for protein in the extracts, were as follows : TNF(-1059)CAT:91.2 ;
TNF(-695)CAT:85.0; TNF(-655)CAT:77 .4 ; TNF(-451)CAT:14.7 ; TNF(-403)CAT :11.6 ;
TNF(-361)CAT:15.9 ; TNF(-301)CAT:28.6 ; TNF(-241)CAT:5 .3 ; TNF(-197)CAT:2 .1 ;
TNF(-144)CAT :2 .5 ; TNF(-109)CAT :1.8;KB/TK 1 :212 .9 ; xB/TK3:0.8;xB/TK 5:120.4; rcB/TK
10:52 .7 ; pBLCAT2:3.9; pSV2CAT:104 .7 .
-316 to -161 (Ava II to FnuD II), were used to assess thepresence ofDNA-binding
proteins in nuclear extracts of resting versus LPS-activated cells . As a control for
the DNA-binding activity of the nuclear extracts, we used a fragment of the cfos
proto-oncogene (nt -350 to -270 ; Pst I to XmaIII) towhich no newproteins bind
after LPSinduction (Collart,M. A., unpublished result). Fig . 4 shows the gelretarda-
tion patterns obtained with these three fragments, using nuclearextracts from un-
treated (R) and LPS-activated (L) peritoneal macrophages. Extracts from bone
marrow-derived macrophagesproduced essentially identical patterns (datanot shown) .
The -695 to -432 fragment formed two complexes (II and IV) with extracts from
resting macrophages, and three additional major complexes (Ia, Ib, and III) with
extracts from LPS-inducedmacrophages . The same resultswere obtainedwhen using40 KB ENHANCERS IN THE TUMOR NECROSIS FACTOR a PROMOTER
a fragment spanning nt -655 (Eco RI) to -432 (Nco I) . With the -316 to -161
fragment, no new complexes were seen in extracts from LPS-activated cells ; how-
ever, we could reproducibly see a two- to threefold increase in the amount of the
slowest-migrating complex formed with this fragment (Fig . 4) . The cfos SRE-
containing fragment yielded identical patterns with extracts from resting or acti-
vated macrophages . All these complexes could be competed out by cold DNA from
the same fragment used forlabeling, but not by irrelevantDNA (data not shown) .
The nucleotide sequence of the region between nt -655 and -427 (Fig . 5) con-
tains two sequence elements with strong similarity to the KB enhancer originally
found in the immunoglobulin is chain gene. Additionally, the sequence around nt
-250 is very similar to the MHC class II "Y box". In order to test whether DNA-
protein contacts within thecomplexesinvolved these consensus sequences, weadded
competing double-stranded oligonucleotides containing these sequences to the gel
retardation assays. In the experiment depicted in Fig. 6 A, we analyzed the effects
ofadded oligonucleotides on DNA-protein complexes generated with the -695 to
-432 fragment . An oligonucleotide spanning nt -521 to -499 (KB; site 3 in Figs .
1 and 7) effectively competed for the formation of complexes Ia, Ib, and III, less
well for complex 11, and not at all for complex IV. A second oligonucleotide span-
ning nt -669 to -636 (CK-1; site 2 in Figs . 1 and 7) completely inhibited the for-
mation ofcomplex IV, and partially inhibited complexes Ia and Ib. An oligonucleo-
tide spanning nt -263 to -223 (Y box) had no effect on protein binding to this
fragment . Thesingle protein-DNA complexmapping to the -316 to -161 fragment
was effectively competed by theY box oligonucleotide, but not by the KB oligonucle-
otide(Fig . 6B) . We conclude from these experimentsthat all ofthedetectableDNA-
protein complexes mapping between -695 and -161 involve sequences from three
sites: two KB-like enhancers, and aMHC class IIYbox.A detailed analysis ofthese
DNA-protein interactions will be published elsewhere (Collart, M. A., and I? Vas-
salli, manuscript submitted for publication) .
The TNF-a KB-type Enhancer Confers LPSResponsiveness to a Heterologous Promoter.
￿
To
test whether the KB-like element centered around nt -510 (site 3) has an LPS-inducible
FIGURE 4 .
￿
Gel retardation assays
usingTNFa promoter fragments
and nuclear extracts from perito-
neal macrophages . Restriction frag-
ments from the TNFci or cfos
promoters were endlabeled and in-
cubated with nuclear extracts from
resting (R) or LPS-stimulated (L)
peritoneal macrophages . Unmarked
lanes contain fragments incubated
without extracts. Gel retardation
assays were performed as described
in Materials and Methods .SHAKHOV ET AL .
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FIGURE 6 .
￿
Competition by oligonucleotides of protein binding
to TNFa promoter fragments. Three double-stranded oligonu-
cleotides corresponding to the sequences of the KB-like sites2(nt
-669 to -636 ; CK-1) and 3 (nt -521 to -497 ; KB), and to the
Y box (nt -263 to -223 ; Y) were used as competitors (at a 50-
fold molar excess) in the gel retardation assays shown in Fig. 4,
usinga nuclear extract from inducedmacrophages. PanelA: -695
to -432 fragment (Sac I to Nco I); panel B : -316 to -161 frag-
ment (Ava II to FnuD II) .
FIGURE 7 .
￿
Sequence homolo-
gies between KB-typeenhancers
found in variousclassesofgenes.
TheAttribution" column indi-
cates whether the enhancer in
question was described as be-
longing to the KB or the "cyto-
kine-1" (CK-1) class . Purines are
printed in boldface, while pyri-
midines are in italics .Themost
conserved nucleotides are shaded.
enhancer activity, we constructed a series of plasmids containing this element cou-
pled to an enhancerless herpes simplex virus thymidine kinase (TK) promoter, and
tested them for inducibility byLPS after transfection intobonemarrowmacrophages .
The pBLCAT2 parental plasmid and the hybrid uB/TK 3 (one copy of the KB en-
hancer) were unresponsive to LPS (Fig . 3) . The uB/TK 10 hybrid (two copies) was
weakly inducible by LPS, while plasmids aB/TK 1 (three copies) and 5 (six copies)
were inducible to a level higher than TNF(-1059)CAT, which contains 1,059 by
ofTNFot 5' flanking sequence.
Discussion
The data presented above demonstrate that primary macrophages derived from
bone marrow cells could be transfected with exogenous DNA, that this DNA was
expressed, and that LPS inducibility was maintained for the transiently expressed
TNFot promoter. There was agood agreement between thedata obtained from the
transient expression of 5' deletion mutants, and those demonstrating LPS-inducedSHAKHOV ET AL.
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sequence-specific DNA binding activities. Theregion between nt -655 andnt -451
was required for maximal LPS induction, and fragments spanning nt -655 to -427
or -695 to -427 formed distinct new complexeswith LPS-induced proteins. These
complexes involved protein bindingto sequence§centered around nt -650 and -510.
Additional deletion of the region between nt -301 and nt -241 abrogated induc-
ibility; similarly, using a fragment spanning nt -316 to -161, we could see a two-
to threefold LPS-mediated increase in the concentration of a specific protein-DNA
complex that maps to a MHC class II Y box.
Fig. 5 shows thesequence oftheTNFa promoter region, with the potentialregula-
tory elements identified in this study. The region between nt -521 and nt -499
contains an element with close similarity to the Ig,Klight chainenhancer, the binding
site for the NFKB protein (21, 22), and to the related enhancers found in the MHC
class I, /32-microglobulin, /3-interferon, IL-2 receptor a chain, and IL-2 genes, in
thelong terminal repeats (LTRs) of HIV-1 and HTLV1, and in the early enhancers
of SV40 and human CMV (21, 23-25). There is ample evidence for the functional
importance of the KB-related enhancers in all ofthese genes (21-26). We have found
that two or more copies of the TNFa KB site conferred LPS inducibility upon a
heterologous promoter.
In addition, threeotherpotential KB enhancers arefoundwithin 1 kb of themRNA
initiation site. The first (nt 862 to -852; site 1 in Figs. 1 and 7) conforms closely
to the KB consensus. The two others (nt -659 to -649, site 2, and -208 to -198,
site 4) arerelatedto the"cytokine-1" motiffound in the IL-2, IL-3, G-CSF, and GM-
CSF promoters (27), and are located in regions of high conservation between the
rabbit, human, and mouse sequences (Fig. 5). At least one nuclear protein bound
to site 2 in theTNFapromoter (Fig. 6). It hasrecently been shown that the"cytokine-1"
site found in the IL-2 promoter actually binds the same proteins as the KB-type en-
hancer of the IL-2 receptor a chain promoter (25). Therefore, it is likely that the
"cytokine-1" motifis in fact a variant of the KB enhancer. Fig. 7 shows a compilation
of enhancer motifs originally assigned to either the KB or the "cytokine-1" classes,
including those from the mouse TNF genes. The most striking features emerging
from this compilation are: (a) the clear separation of purines (boldface) and pyrimi-
dines (italics) in the enhancer motif; (b) the presence of three essentially invariant
nucleotides.
The presence of one copy of the «B enhancer is probably not sufficient for LPS-
inducibleexpression in macrophages, sincethe TNF0 gene, which contains a single
copy of the motif, is not expressed in these cells, either naturally or in our transfec-
tion assay, and since the aB/TK construct with a single copy of the enhancer was
not inducible either. Therefore, it is likely that more than one KB-type enhancer
participates in activation of the TNFct promoter. This interpretation is also consis-
tent with the results ofourdeletion analysis, where loss ofthesecond andthird potential
KB sites correlated with loss of LPS inducibility, and with preliminary data indi-
cating that the deletion ofasingle KB site was notsufficient to abolish LPS inducibility.
A recent study (28) suggested that KB-type enhancers may be active in all mature
macrophage populations; this is consistent with our earlier observation of a basal
activity ofthe TNFac promoter in resting macrophages (2, 10). However, ouraB/TK
constructs were expressed at very low levels in bone marrow-derived macrophages,44
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butcouldbe fullyactivated by as little as 10 ng/ml LPS(data notshown). Therefore,
we would argue that exposure to LPS or similar macrophage-activating agents is
necessary for maximal expression of genes controlled by KB-type enhancers.
The region between nt -301 and -241, where residual LPS inducibility was lost
in the 5' deletion series, contains only a Ybox, similarto those found in the promoters
of MHC class II genes (29-31), and a (CA) microsatellite. In addition, LPS in-
duced an increase in the concentration of a protein binding to the Y box (nt -263
to -223). This indicates that the Ybox maybe important forthe inductionof TNFa
transcription, and that there may be common elements involved in the regulation
ofTNF-a and MHC class II genes. Experiments exploring the expression of MHC
class II promoter mutants in transgenic mice suggest that theY box has a particular
importance formacrophage-specific gene expression, and forinducibility by IFN-'Y
(29, 30). It should be stressed, however, that LPS alone not only failsto induce MHC
class II gene expression, but actually inhibits it (32). Therefore, it is very unlikely
that the Y box alone could confer LPS inducibility. The presence of a Y box in the
TNFac, but not theTNF(3 promoter argues forarole of this element in macrophage-
specific expression.
A recent article (33) reported that 95 nt of the human TNFa promoter region
are sufficient for full induction by PMA in the U937 promonocytic cell line. These
95 nt do not contain either of the KB-like elements found in the human promoter
(Fig. 5). On the otherhand, a NF-KB-like protein is induced by PMA in U937 cells
(28). It is conceivable that PMA, but not LPS, can trigger a KB-independent activa-
tion pathway; alternatively, the human gene may contain promoter proximal en-
hancer elements not found in the mouse. The latter explanation seems less likely,
as the nucleotide sequence between -200 and +1 is highly conserved between spe-
cies (Fig. 5).
The data presented in this article provide additional evidence forthe ubiquitous
role of NFKB and related proteins as transducers of extracellular signals affecting
the physiological state of avariety of cell types (26). In macrophages, NF-KB seems
to have a central role in the initial activation event triggered by LPS, and in the
transcriptional activation of the TNFa gene. Other signals, carried by proteins in-
teracting with the Y box, are probably also involved in modulating the activity of
the TNFa promoter.
Summary
We have explored the cis-acting elements necessary for the LPS-mediated activa-
tion ofthe mouse TNFa promoter by transfecting aset of5' deletion mutantslinked
to the CAT reporter gene into primarybone marrow-derived macrophages. A major
drop in inducibility by LPS was seen upon deletion of a region mapping between
nt -655 and nt -451. Gel retardation assays revealed that LPS induced the appear-
ance in this region of several specific DNA-protein complexes mappingto sequence
motifs with strong homology to theKB enhancer. Constructs containing two or more
copies of one of the KB enhancer motifs linked to a heterologous promoter were in-
ducibleby LPS. Additional deletion ofaregion between nt -301 and nt- 241, which
contains a MHC class II-like "Y box" and formed a Y box-specific complex withSHAKHOV ET AL.
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a protein whose concentration was increased by LPS, caused a nearly complete loss
of inducibility by LPS. We speculate that NF-KB and/or related proteins are involved
in the LPS-induced transcriptional activation of the TNFa gene, and that factors
interacting with the Y box can additionally modulate the activity ofthe gene in mac-
rophages.
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